Effectiveness and Implementation of mPATH-CRC: a Mobile Health System for Colorectal Cancer Screening

mPATH-CRC 的有效性和实施:用于结直肠癌筛查的移动医疗系统

基本信息

  • 批准号:
    10165873
  • 负责人:
  • 金额:
    $ 22万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-06-01 至 2021-05-31
  • 项目状态:
    已结题

项目摘要

Abstract As outlined in the NIH Strategic Plan for Data Science, recent advances in computing technology have improved the ability to create interoperable and scalable electronic health record (EHR) integrated software using WebServices (e.g., application programming interfaces, APIs) and cloud-based computing architecture. The current leading standard for health care data exchange is Fast Health Interoperability Resources (FHIR), published by the HL7® working group. FHIR is a specification that provides standardized data models and APIs for managing health care data, and represents a simplification and expansion of earlier HL7 standards. The SMART on FHIR standard allows the integration of apps within a clinical workflow, including contextual embedding, authorization, and single sign-on. As technology evolves, EHRs have increasingly adopted more of a platform role, enabling third-party applications to perform limited functions within the system of record. Interoperable standards-based information systems that facilitate the secure but agile exchange of data are critical to contemporary healthcare delivery. Cloud-based services are widely used in the non-healthcare domain. EHR-integrated digital and mobile health applications must include expanded use of the SMART on FHIR standard and cloud base architecture to allow for scalability and ease of installation across healthcare systems and care settings. Our team, which includes board-certified clinical informaticists and Epic-certified programmers, has deep expertise creating multilevel digital health interventions that target the patient, clinician, and healthcare system to increase the uptake of guideline-recommended cancer screening. In a prior multisite randomized controlled trial, our highly successful mPATHTM-CRC (mobile PAtient Technology for Health-Colorectal Cancer) iPad app doubled the proportion of patients who were screened for colorectal cancer. We are currently conducting a hybrid implementation- effectiveness trial of mPATHTM-CRC in 28 community-based clinics (R01CA218416-A1). As part of the parent award, we determined the best way to integrate mPATHTM-CRC in clinical workflow. We then spent 9 months converting mPATHTM- CRC from a stand-alone iPad app to one that is fully-integrated with Wake Forest’s Epic EHR. To date, we have launched the new EHR-integrated mPATHTM program in 6 of our planned 28 clinics. Prior to COVID-19, over 15,000 patients had used mPATHTM, which identified over 1100 patients who were overdue for CRC screening by a mean of 10 years. The specific aims of this supplement are to: (1) Enhance the mPATHTM-CRC application’s interoperability and decrease EHR- vendor specific dependencies by leveraging WebServices and SMART on FHIR; (2) re-engineer mPATHTM-CRC from a containerized, on-premise architecture to a service-agnostic cloud-based architecture; and (3) validate the interoperable (SMART on FHIR leveraging OAUTH2.0) and cloud-based architecture through rigorous testing. Achieving these aims will greatly increase the impact of the platform and contribute to the literature for open-standards based software development. Additionally, this project will yield essential information for the successful implementation of other technology-mediated interventions in healthcare settings.
抽象的 正如 NIH 数据科学战略计划中所述,计算技术的最新进展提高了 使用 Web 服务创建可互操作且可扩展的电子健康记录 (EHR) 集成软件的能力 (例如,应用程序编程接口、API)和基于云的计算架构。 用于医疗保健数据交换的是快速健康互操作性资源 (FHIR),由 HL7® 工作组发布。 FHIR 是一种规范,提供用于管理医疗保健数据的标准化数据模型和 API,代表了 SMART on FHIR 标准的简化和扩展允许在其中集成应用程序。 临床工作流程,包括上下文嵌入、授权和单点登录 随着技术的发展,EHR 已经实现了。 越来越多地采用平台角色,使第三方应用程序能够在平台内执行有限的功能 可互操作的基于标准的信息系统,促进安全而敏捷的信息交换。 数据对于当代医疗保健服务至关重要基于云的服务广泛应用于非医疗保健领域。 EHR 集成数字和移动医疗应用程序必须包括在 FHIR 上扩展 SMART 的使用。 标准和云基础架构,可实现跨医疗保健系统和护理的可扩展性和易于安装 我们的团队包括经过委员会认证的临床信息学家和 Epic 认证的程序员,拥有深厚的背景。 专业知识创建多层次的数字健康干预措施,针对患者、临床医生和医疗保健系统 在之前的多中心随机对照试验中,增加了指南推荐的癌症筛查的采用率。 非常成功的 mPATHTM-CRC(移动患者健康技术 - 结直肠癌)iPad 应用程序使 我们目前正在进行一项混合实施—— mPATHTM-CRC 在 28 个社区诊所进行的有效性试验 (R01CA218416-A1) 作为家长奖励的一部分,我们。 确定了将 mPATHTM-CRC 集成到临床工作流程中的最佳方法,然后我们花了 9 个月的时间转换 mPATHTM-。 CRC 从一款独立的 iPad 应用程序到与维克森林大学的 Epic EHR 完全集成的应用程序 迄今为止,我们已经推出了。 在 COVID-19 之前,我们计划在 28 家诊所中的 6 家实施新的 EHR 集成 mPATHTM 计划,已有超过 15,000 名患者接受过治疗。 使用 mPATHTM,它发现了超过 1100 名平均逾期 10 年才进行 CRC 筛查的患者。 本补充的具体目标是: (1) 增强 mPATHTM-CRC 应用程序的互操作性并减少 EHR- 通过利用 FHIR 上的 WebServices 和 SMART 来重新设计 mPATHTM-CRC; 容器化的本地架构到与服务无关的基于云的架构;(3) 验证可互操作性; (SMART on FHIR 利用 OAUTH2.0)和基于云的架构将通过严格的测试实现这些目标。 极大地提高了平台的影响力,并为基于开放标准的软件文献做出了贡献 此外,该项目将为其他项目的成功实施提供重要信息。 医疗保健环境中以技术为媒介的干预措施。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David P Miller其他文献

Color Doppler and two-dimensional echocardiographic determination of the mechanism of aortic regurgitation with surgical correlation.
彩色多普勒和二维超声心动图测定主动脉瓣关闭不全的机制与手术的相关性。
Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology. EPIC and EPILOG Investigators. Evaluation of 7E3 for the Prevention of Ischemic Complications. Evaluation of PTCA To Improve Long-term Outcome with abciximab GPIIb/IIIa Receptor Block
阿昔单抗对血管成形术并发症的减少很大程度上与基线病变形态无关。
  • DOI:
    10.1016/s0735-1097(98)00403-3
  • 发表时间:
    1998
  • 期刊:
  • 影响因子:
    24
  • 作者:
    Stephen G. Ellis;A. Lincoff;David P Miller;J. Tcheng;N. Kleiman;D. Kereiakes;R. Califf;E. Topol
  • 通讯作者:
    E. Topol
Long‐Term Protection from Myocardial Ischemic Events in a Randomized Trial of Brief Integrin β3 Blockade with Percutaneous Coronary Intervention
经皮冠状动脉介入治疗短暂整合素 β3 阻断的随机试验对心肌缺血事件的长期保护
  • DOI:
    10.1097/00132586-199808000-00009
  • 发表时间:
    1998
  • 期刊:
  • 影响因子:
    0
  • 作者:
    E. Topol;J. Ferguson;H. Weisman;J. Tcheng;S. Ellis;N. Kleiman;R. Ivanhoe;Ann L. Wang;David P Miller;K. Anderson;R. Califf
  • 通讯作者:
    R. Califf
Benefit of early sustained reperfusion in patients with prior myocardial infarction (the GUSTO-I trial). Global Utilization of Streptokinase and TPA for occluded arteries.
早期持续再灌注对既往心肌梗塞患者的益处(GUSTO-I 试验)。
  • DOI:
  • 发表时间:
    1998
  • 期刊:
  • 影响因子:
    2.8
  • 作者:
    D. Brieger;K. Mak;H. White;N. Kleiman;David P Miller;A. Vahanian;A. Ross;R. Califf;E. Topol
  • 通讯作者:
    E. Topol
Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention. EPIC Investigator Group. Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Complication.
在一项短期整合素 β3 阻断联合经皮冠状动脉介入治疗的随机试验中,可长期预防心肌缺血事件。
  • DOI:
  • 发表时间:
    1997
  • 期刊:
  • 影响因子:
    0
  • 作者:
    E. Topol;J. Ferguson;H. Weisman;J. Tcheng;Stephen G. Ellis;N. Kleiman;R. Ivanhoe;Ann L. Wang;David P Miller;K. Anderson;R. Califf
  • 通讯作者:
    R. Califf

David P Miller的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David P Miller', 18)}}的其他基金

A cloud-based digital health navigation program for colorectal cancer screening
基于云的结直肠癌筛查数字健康导航程序
  • 批准号:
    10697474
  • 财政年份:
    2023
  • 资助金额:
    $ 22万
  • 项目类别:
A Personalized Digital Outreach Intervention for Lung Cancer Screening
肺癌筛查的个性化数字外展干预措施
  • 批准号:
    10551856
  • 财政年份:
    2020
  • 资助金额:
    $ 22万
  • 项目类别:
A Personalized Digital Outreach Intervention for Lung Cancer Screening
肺癌筛查的个性化数字外展干预措施
  • 批准号:
    10318171
  • 财政年份:
    2020
  • 资助金额:
    $ 22万
  • 项目类别:
A Personalized Digital Outreach Intervention for Lung Cancer Screening
肺癌筛查的个性化数字外展干预措施
  • 批准号:
    9885242
  • 财政年份:
    2020
  • 资助金额:
    $ 22万
  • 项目类别:
A Personalized Digital Outreach Intervention for Lung Cancer Screening
肺癌筛查的个性化数字外展干预措施
  • 批准号:
    10062917
  • 财政年份:
    2020
  • 资助金额:
    $ 22万
  • 项目类别:
Effectiveness and Implementation of mPATH-CRC: a Mobile Health System for Colorectal Cancer Screening
mPATH-CRC 的有效性和实施:用于结直肠癌筛查的移动医疗系统
  • 批准号:
    9895633
  • 财政年份:
    2018
  • 资助金额:
    $ 22万
  • 项目类别:
Effectiveness and Implementation of mPATH-CRC: a Mobile Health System for Colorectal Cancer Screening
mPATH-CRC 的有效性和实施:用于结直肠癌筛查的移动医疗系统
  • 批准号:
    10116309
  • 财政年份:
    2018
  • 资助金额:
    $ 22万
  • 项目类别:
Effectiveness and Implementation of mPATH-CRC: a Mobile Health System for Colorectal Cancer Screening
mPATH-CRC 的有效性和实施:用于结直肠癌筛查的移动医疗系统
  • 批准号:
    10382400
  • 财政年份:
    2018
  • 资助金额:
    $ 22万
  • 项目类别:
Institutional Career Development Core
机构职业发展核心
  • 批准号:
    10440530
  • 财政年份:
    2015
  • 资助金额:
    $ 22万
  • 项目类别:
Institutional Career Development Core
机构职业发展核心
  • 批准号:
    9902913
  • 财政年份:
    2015
  • 资助金额:
    $ 22万
  • 项目类别:

相似海外基金

The RaDIANT Health Systems Intervention for Equity in Kidney Transplantation
Radiant 卫生系统干预肾移植的公平性
  • 批准号:
    10681998
  • 财政年份:
    2023
  • 资助金额:
    $ 22万
  • 项目类别:
Testing and Texting in Community Health Center Dental Clinics to Diagnose and Prevent HIV Infection
在社区健康中心牙科诊所进行检测和发短信以诊断和预防艾滋病毒感染
  • 批准号:
    10864322
  • 财政年份:
    2023
  • 资助金额:
    $ 22万
  • 项目类别:
Undergraduate Research Training Initiative for Student Enhancement (U-RISE) (T34) at CSULB
CSULB 本科生研究培训计划 (U-RISE) (T34)
  • 批准号:
    10627654
  • 财政年份:
    2023
  • 资助金额:
    $ 22万
  • 项目类别:
Sustainability determinants of an intervention to identify clinical deterioration and improve childhood cancer survival in low-resource hospitals
在资源匮乏的医院中识别临床恶化并提高儿童癌症生存率的干预措施的可持续性决定因素
  • 批准号:
    10562780
  • 财政年份:
    2023
  • 资助金额:
    $ 22万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10668162
  • 财政年份:
    2023
  • 资助金额:
    $ 22万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了